Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Daiichi Sankyo Co., Ltd.
Age
20–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female subjects aged 20 to 80 years at informed consent
Subjects with severe hypertension, who do not receive any antihypertensive drugs or receive antihypertensive drug (except for potassium-sparing diuretics) during run-in period (Sitting SBP ≥ 180 mmHg or Sitting DBP ≥ 110 mmHg)
You may not be if
Patients who are suspected hypertensive emergency
Secondary hypertension or malignant hypertension
Diabetes mellitus with albuminuria
Serum potassium level \< 3.5 or ≥ 5.1 mEq/L (≥ 4.8 mEq/L if receive RA inhibitor)
eGFR \< 60 mL/min/1.73 m\^2.
Clareo Health | Study of CS-3150 in Patients With Severe Hypertension
